BioChaperone^TM technology is a versatile and broad platform which can be applied to a vast number of proteins such as other growth factors, therapeutic proteins or enzymes.

BioChaperone^TM has already shown its ability to stabilize, solubilize and potentiate a broad range of clinically relevant proteins.

Adocia has started some collaborative programs to improve the efficacy of marketed proteins and new therapeutic proteins with BioChaperone^TM.

Adocia is open to evaluate the benefit of BioChaperone^TM platform for your proteins.

Please contact Adocia’s Chief Executive Officer, Gérard Soula.